Recombinase Polymerase Amplification Assay for Rapid Diagnostics of Dengue Infection by Abd El Wahed, Ahmed et al.
HAL Id: pasteur-02082161
https://hal-pasteur.archives-ouvertes.fr/pasteur-02082161
Submitted on 28 Mar 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
Recombinase Polymerase Amplification Assay for Rapid
Diagnostics of Dengue Infection
Ahmed Abd El Wahed, Pranav Patel, Oumar Faye, Sasikanya Thaloengsok,
Doris Heidenreich, Ponpan Matangkasombut, Khajohnpong
Manopwisedjaroen, Anavaj Sakuntabhai, Amadou Sall, Frank Hufert, et al.
To cite this version:
Ahmed Abd El Wahed, Pranav Patel, Oumar Faye, Sasikanya Thaloengsok, Doris Heidenreich, et
al.. Recombinase Polymerase Amplification Assay for Rapid Diagnostics of Dengue Infection. PLoS
ONE, Public Library of Science, 2015, 10 (6), pp.e0129682. ￿10.1371/journal.pone.0129682￿. ￿pasteur-
02082161￿
RESEARCH ARTICLE
Recombinase Polymerase Amplification
Assay for Rapid Diagnostics of Dengue
Infection
Ahmed Abd El Wahed1,2, Pranav Patel3, Oumar Faye4, Sasikanya Thaloengsok5,
Doris Heidenreich6, Ponpan Matangkasombut5,7, Khajohnpong Manopwisedjaroen5,
Anavaj Sakuntabhai8, Amadou A. Sall4, Frank T. Hufert9, ManfredWeidmann10*
1 Unit of Infection Models, German Primate Center, Goettingen, Germany, 2 Department of Virology,
Mansoura University, Dakahlia, Egypt, 3 CBS1-Highly Pathogenic Viruses, Center for Biological Threats and
Special Pathogens, Robert Koch Institute, Berlin, Germany, 4 Arbovirus Unit, Pasteur Institute, Dakar,
Senegal, 5 Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand,
6 Department of Virology, University Medical Center, Goettingen, Germany, 7 Systems Biology of Diseases
Research Unit at Faculty of Science and Center of Emerging and Neglected Infectious Diseases, Mahidol
University, Bangkok, Thailand, 8 Functional Genetics of Infectious Diseases Unit, Institute Pasteur, Paris,
France, 9 Institute of Microbiology and Virology, Brandenburg Medical School Theodor-Fontane,
Senftenberg, Brandenburg, Germany, 10 Institute of Aquaculture, University of Stirling, Stirling, Scotland,
United Kingdom
* m.w.weidmann@stir.ac.uk
Abstract
Background
Over 2.5 billion people are exposed to the risk of contracting dengue fever (DF). Early diag-
nosis of DF helps to diminish its burden on public health. Real-time reverse transcription po-
lymerase amplification assays (RT-PCR) are the standard method for molecular detection
of the dengue virus (DENV). Real-time RT-PCR analysis is not suitable for on-site screening
since mobile devices are large, expensive, and complex. In this study, two RT-recombinase
polymerase amplification (RT-RPA) assays were developed to detect DENV1-4.
Methodology/Principal Findings
Using two quantitative RNAmolecular standards, the analytical sensitivity of a RT-RPA tar-
geting the 3´non-translated region of DENV1-4 was found to range from 14 (DENV4) to 241
(DENV1-3) RNA molecules detected. The assay was specific and did not cross detect other
Flaviviruses. The RT-RPA assay was tested in a mobile laboratory combining magnetic-
bead based total nucleic acid extraction and a portable detection device in Kedougou (Sen-
egal) and in Bangkok (Thailand). In Kedougou, the RT-RPA was operated at an ambient
temperature of 38°C with auxiliary electricity tapped from a motor vehicle and yielded a clini-
cal sensitivity and specificity of 98% (n=31) and 100% (n=23), respectively. While in the
field trial in Bangkok, the clinical sensitivity and specificity were 72% (n=90) and 100%
(n=41), respectively.
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Conclusions/Significance
During the first 5 days of infection, the developed DENV1-4 RT-RPA assays constitute a
suitable accurate and rapid assay for DENV diagnosis. Moreover, the use of a portable fluo-
rescence-reading device broadens its application potential to the point-of-care for outbreak
investigations.
Introduction
Dengue virus (DENV) is a mosquito-transmitted virus that causes mild ((dengue fever (DF))
to severe disease ((dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)) in
humans [1]. DENV consists of four serotypes (DENV1-4) each comprising multiple genotypes
and belongs to the genus Flavivirus of the family Flaviviridae [2].
Before 1970 DENV outbreaks were reported in nine countries but has since expanded to
more than 100 countries, with an estimated 96 million apparent and 294 million unapparent
cases in 2010 [3]. Two and a half billion people are at risk of infection worldwide [4]. Since spe-
cific treatment or a vaccine are currently not available [5], early detection plays a key role for
initiation of control and preventive measures in dengue endemic regions such as mosquito
control and social mobilization [6].
DENV is detectable in blood up to 5–7 days after the onsets of symptoms. From the 5th day,
diagnosis depends mainly on detection of specific IgM and IgG antibodies using ELISA meth-
ods [7, 8]. Therefore, both virus and antibody detection are crucial for the identification of in-
fected cases. The reference method of DENV diagnosis is virus isolation [9, 10], which takes a
week and requires highly equipped laboratories. The most widely used methods are antigen de-
tection in ELISA or rapid diagnostic tests (RDTs) formats [8]. Antigen detection is based on
the non-structural protein 1 (NS1) of the DENV [11]. RDTs are fast (10–15 minutes) and suit-
able for point-of-care screening. However, RDTs clinical sensitivity (21–99%) and specificity
(77%–98%) vary greatly [7, 8, 12, 13]. The gold standard method for molecular detection of
DENV is real-time RT-PCR, which detects DENV RNA within 60–90 minutes [14–16]. Real-
time RT-PCR is highly sensitive and specific [14, 16–18]. It requires precautions (carry over
prevention systems and physical separation of pipetting sites), sophisticated equipment, and is
cold chain dependent, which makes it difficult to implement at the point-of-need.
Isothermal DNA amplification methods represent an alternative to real-time PCR. There
is only one development for the application of Nucleic acid sequence based amplification
(NASBA) [19] but several applications of reverse transcription Loop mediated isothermal am-
plification (RT-LAMP) for the detection and differentiation of DENV serotypes have been
described [20–23]. RT-LAMP reactions are performed at 60°C, tests run for more than 30 min-
utes, and results are measured either by turbidity index or by visual qualitative fluorescence
detection of SYBR Green [24]. In contrast, real-time recombinase polymerase amplification
(RPA) amplifies at 39–42°C and uses a fluorescent exo-probe for detection [25]. The RPA
assay is very fast (3–15 minutes) and can be operated on a portable device, the tubescanner
(19x17.5 cm). In this study, a-point-of-need reverse transcription RPA (RT-RPA) assays for
the detection of DENV1-4 without differentiation between the serotypes were developed and
evaluated with samples from Senegal and Thailand. A mobile RPA unit was deployed to
Kedougou in Senegal and to Bangkok, Thailand.
Mobile Detection of Dengue Virus
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Methods
Ethics Statement
Human samples tested in Senegal were provided by the WHO collaborating center for Abo-
virus and Viral Hemorrhagic Fever at the Institute Pasteur de Dakar (IPD). The IPD has the re-
quired ethical approvals from the Senegalese National Health Research Council and the signed
consent forms from patients. The ethical committee refernce number is 2472. Human samples
tested during the field trial in Thailand were used after an approval of Faculty of Medicine,
Vajira Hospital, Bangkok, Thailand Research Ethics Committee (Certificate of approval num-
ber: COA29/2012) and signed consent forms from patients.
Viruses
Robert Koch Institute, Berlin, Germany provided the viruses and/or nucleic acids used in this
study. Viruses are listed in Table 1.
Generation of molecular RNA standard
According to a previously published protocol, two in vitro transcribed RNA standards were
prepared [26, 27]. PCR primers used for the amplification of the target region for ligation into
the TA cloning vector pCRII are listed in Table 2. DENV1-3 and DEN4 RNAmolecular stan-
dards cover 242 and 248 bp of the 3’ non-translated region (3’NTR) (10462–10703 nt and
10398–10645 nt of GenBank accession numbers AY662691.1 and GU289913.1), respectively.
The RNA standards were tested by using a published real-time RT-PCR [28]. The Light Cycler
2.0 and the LightCycler 480 RNAMaster Hydrolysis Probes kit (Roche, Manheim, Germany)
were used. The following temperature profile was used: RT step 63°C/3 minutes, initial activa-
tion at 95°C/30 seconds, 45 cycles of 95°C/15 seconds and 60°C/60 seconds, and a final cooling
step of 40°C/30 seconds.
Table 1. List of viral RNA tested.
Name Strain DENV1-3 RT-RPA DENV4 RT-RPA
Dengue virus serotype 1 VR344 (Thai 1958) + -
Dengue virus serotype 2 VR345 (TH-36) + +
Dengue virus serotype 3 VR216 (H87) + -
Dengue virus serotype 4 VR217 (H241) - +
Yellow Fever virus 17D - -
Yellow Fever virus Asibi - -
Tick Borne Encepahlitis virus-FE Far eastern subtype - -
Chikungunya virus LR 2006 - -
Zika virus MR766 - -
Tick-borne encephalitis virus K23 - -
Japanese encephalitis virus ATCC SA14142 - -
West Nile virus Israel - -
DENV1-3 RT-RPA assay detected DENV1-3 but not other viral RNA. DENV4 RT-RPA identified DENV2 and DENV4.
+, positive;-, negative.
doi:10.1371/journal.pone.0129682.t001
Mobile Detection of Dengue Virus
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RT-RPA primers and exo-probes
Two RT-RPA assays were developed to cover DENV1-4, one to detect DENV1-3 and another
to detect DENV4. The assays were not used for distinguishing between DENV serotypes. Nine-
teen forward primers (FP), 5 reverse primers (RP), and 3 exo-probes (exo-Ps) (S1 Fig) were
used to select the combination producing the highest analytical sensitivity for the DENV1-3
RT-RPA assay. Three FP, 2 RP, and 2 exo-P were tested for the DENV4 RT-RPA assay (S2
Fig). Oligonucleotides were synthesized by TIB MOLBIOL (Berlin, Germany).
RT-RPA assay conditions
In the laboratory, the RT-RPA assay was carried out using the TwistAmp exo kit (TwistDx,
Cambridge, UK) and the reverse transcriptase (RT) Transcriptor (Roche, Mannheim, Ger-
many) was added as described [29, 30]. In the field trials in Senegal and Thailand, the RT-RPA
assay was performed using the ready-to-use TwistAmp RT exo (TwistDx, Cambridge, UK) as
described previously [26].
Analytical sensitivity of RT-RPA assays
A dilution range from 107 to 101 RNA molecules/μl of the molecular standards in eight repli-
cates was used to determine the analytical sensitivity of RT-RPA assays. A semi-log and probit
regression analyses were performed as stated in the statistical analysis section (see below).
Specificity and cross-reactivity of RT-RPA assays
The specificity of the DENV RT-RPA assays was determined by testing 64 DENV-real-time
RT-PCR negative plasma samples (41 samples during the field trial in Thailand and 23 in
Senegal). In addition, genomic RNA of the Yellow Fever virus, Tick-borne encephalitis virus,
Table 2. Sequence of primers and probes for the construction of molecular standards, real-time RT-PCR and RT-RPA assays.
Name Sequence 5’-3’ Amplicon size
bp
DENV1-3-STD-UP CTGTACGCACGGTGTAGCAGAC 242
DENV1-3-STD-DP CCTGTTGATTCAACAGCACCATTC
DENV4-STD-UP CTGTACGCGTGGCATATTG 248
DENV4-STD-DP CCTGTTGGATCAACAACACC
DENV-PCR-FP AAGGACTAGAGGTTAKAGGAGACCC 85
DENV-PCR-RP CTGHRGAGACAGCAGGATCTCTG
DENV-PCR-P FAM-AACAGCATATTGACGCTGGGARAGAC-TAMRA
DENV1-
3-RPA-FP13
ATTCAACAGCACCATTCCATTTTCTGGCGTTCTGTG 97
DENV1-3-RPA-RP4 AACAGCATATTGACGCTGGGAGAGACCAGAGATC
DENV4-RPA-FP3 CATCTTGCGGCGCTCTGTGCCTGGATTGA 86
DENV4-RPA-RP2 CACAAAAACAGCATATTGACGCTGGGAAAG
DENV-RPA-P3 ATATTGACGCTGGGAGAGACCAGAGATCCTGC(BHQ1-dT)(THF)(FAM-dT)CTCCTCAGCATCATTC-
(Phosphate)
N/A
Bp, base pair; DENV1-3-STD-UP/DP are for DENV1-3 RT-PCR; DENV4-STD-UP/DP are for DENV4 RT-PCR; DENV-PCR-FP/RP/P, real-time RT-PCR
primers and Taqman probe (FAM/TAMRA); DENV1-3-RPA-FP, forward and reverse primers for DENV1-3 RT-RPA; DENV4-RPA-FP, forward and reverse
primers for DENV4 RT-RPA; DENV-RPA-P, exo-probe; BHQ1-dT: thymidine nucleotide carrying Blackhole quencher1, THF: tetrahydrofuran spacer, FAM-
dT: thymidine nucleotide carrying Fluorescein. N/A, non applicable.
doi:10.1371/journal.pone.0129682.t002
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Tick-borne encephalitis virus-Far East, Chikungunya virus, Zika virus, Japanese encephalitis
virus and West Nile virus were tested for cross-reactivity.
Differentiation between specific and non-specific signals of the RT-RPA
Real-time fluorescence development in the RT-RPA reaction was measured with the tubescan-
ner (Qiagen Lake Constance GmbH, Stockach, Germany). Fluorescence signals were analyzed
by using the tubescanner studio software (Qiagen Lake Constance GmbH, Stockach, Ger-
many). It allows an analysis of accumulative fluorescence intensity over time by threshold vali-
dation to identify the increase of fluorescence over time above the mean background signal
(raw data, Fig 1A and 1C). Additionally, slope validation is used to verify that the increase of
fluorescence occurs at a sufficiently high rate, this can be displayed as a 1st derivative analysis
(1st derivative analysis, Fig 1B and 1D).
Specific amplification (black curves Fig 1) should present ascending curves indicating in-
crease of florescence over time in both analyses. Negative or non-specific amplification (blue
curves Fig 1) might in a few cases develop fluorescence in the raw data view but never in the 1st
derivative analysis. The derivative analysis is therefore necessary to confirm true amplification.
RT-RPAmobile laboratory
The mobile laboratory was organized into four sites in close proximity, which included the ex-
traction, the master mix, the sample mix, and the detection-sites (Fig 2). The RNA extraction
was done by using a extraction kit based on magnetic beads (Dynabeads SILANE viral NA, Life
Technologies, Darmstadt, Germany) according to the manufacturer instructions. The DENV
RT-RPA assays were performed by using the ready-to-use TwistAmp exo RT kits (TwistDx,
Cambridge, UK), dried DENV1-3 and DENV4 in vitro transcribed RNA (using the RNAstable
Fig 1. Differentiation between specific and non-specific signals of the RT-RPA assay. A and C are real-time fluorescence intensity; B and D are the 1st
derivative analysis. Specific DNA amplification represented by progressive fluorescence development in both views, A and B, while non-specific not. Black
line shows specific amplification where blue line shows no amplification.
doi:10.1371/journal.pone.0129682.g001
Mobile Detection of Dengue Virus
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kit, Biomatrica, Inc. San Diego, CA, USA), and dried RT-RPA oligonucleotides (TIB MOL-
BIOL, Syntheselabor, Berlin, Germany).
Oligonucleotide sets were ordered as dried pellets at an absolute concentration of 840 pmol
primers/400 pmol probe. The addition of 200 μl water yielded a stock solution of 4.2 μM/2 μM
from which the final concentration of 420 nM/200 nM of the RT-RPA reaction was derived by
10-fold dilution. One 200 μl 40x stock solution thus allowed pipette eight 9-volume master
mixes to fill eight 8-tube strips for the tubescanner device. For the positive control, one volume
of the master-mix was added to a dried positive control tube.
All reagents used for the mobile laboratory were cold-chain independent, i.e. used stored,
and transported at ambient temperature. Electricity was either tapped from a motor vehicle
battery via inverter (HPL 1200-D-12 inverter 12V 1200W) or supplied via solar panel and
power pack (Yeti 1250 set, GOALZERO, South Bluffdale, UT, USA).
Field trial in the Kedougou region, Senegal
The mobile RPA was tested in the field station of the IPD in Kedougou, Senegal. Additionally,
the mobile RPA laboratory was transferred to a health care station in Bandafasi, Kedougou for
Fig 2. RPAmobile laboratory. The extraction area encompassing magnetic separator stand, vortex, rotator, 1.5–2 ml eppendorf tube rack, automatic 100–
1000 μl micopipette, micropipette tips, digital timer, 1.5 ml disposable plastic Eppendorf tubes, and a waste container with autoclavable plastic bags. Both
master mix and sample mix areas contain vortex, minicentrifuge, automatic 1–10 and 10–100 μl micopipettes, micropipette tips, scissor, and 0.2 ml tubes
rack. The detection was done using the tubescanner (Twista device, TwistDx, Cambridge, UK). In addition to a waste container, gloves, disposable towels,
and aluminum box with trolley (740x490x450 mm, ZARGES, Weilheim, Germany).
doi:10.1371/journal.pone.0129682.g002
Mobile Detection of Dengue Virus
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use in very simple conditions with auxiliary electricity tapped from a motor vehicle. Inactivated
DENV1-4 cell culture supernatants (heating at 56°C/1 hour and gamma irradiation with 30
kGy) and thirty-one DENV RNA positive samples were tested in triplicate.
Evaluation of RT-RPA assay using RNA extracts in Bangkok, Thailand
RNA extracted from ninety selected samples, positive by SD Dengue Duo Rapid Test (Standard
Diagnostic, Inc, Republic of Korea), by QIAamp Viral RNAMini Kit (Qiagen, Hilden, Ger-
many) and stored between 6–18 months at -80°C. RNA was retested simultaneously with real-
time RT-PCR and the RT-RPA assays, each sample was tested at least twice. The real-time
RT-PCR was performed by using the Light Cycler 480 RNAMaster Hydrolysis Probes kit
(Roche, Germany) using the following temperature profile: 61°C for 10 minutes, 95°C for 2
minutes followed by 45 cycles of 95°C for 15 seconds and 60°C for 30 seconds on a 7500 Fast
Real-Time PCR system. Data were analyzed using the 7500 Fast Real-Time PCR software pro-
vided by Applied Biosystem 7500 Fast Real-Time PCR system (Life technologies, USA). The
primers and probe targeted the NS5 gene (S1 Table, [14]).
Statistical analysis
The semi-log regression analyses of the analytical sensitivity of RT-RPA assays were performed
using PRISM (Graphpad Software Inc., San Diego, CA, USA) and the probit anylsis by STA-
TISTICA (StatSoft, Hamburg, Germany). Comparison between real-time RT-PCR and
RT-RPA for the detection of DENV was performed by linear regression analysis using Prism.
Results
Analytical sensitivity of DENV1-3, and DENV4 RT-RPA assays
Due to the variability of DENV sequences in the 3’NTR, two RT-RPA assays were designed,
one for the detection of DENV1-3 and one for the detection of DENV4. The primers DENV1-
3-RPA-FP13 and RP4 and the primers DENV4-RPA-FP3 and RP2 both in combination with
DENV-RPA-P3 yielded analytical sensitivities between 10–100 RNA molecules (Table 2 and
Fig 3). Most of the other primer and exo-P combinations produced either non-specific amplifi-
cation (S3 Fig) or analytical sensitivity between 105–103 RNA molecules (S4 Fig). Using the
data of eight RT-RPA runs on the quantitative RNA standard, a semi-log regression (Fig 4)
and probit regression analysis were performed. For both assays, the runtime was 3–7 minutes
at an efficiency of 0.24 and 0.27 calculated from the linear slopes (-0.2366 and -0.1655) of the
semi-log standard regression (E = 10(-1/slope)-1) for DEN1-3 and DEN4 RT-RPA assays, respec-
tively. Probit regression yielded a sensitivity at 95% of 241 and 14 RNAmolecules detected for
the DENV1-3 and the DENV4 RT-RPA assays, respectively. Additionally, inactivated whole
DENV1-4 (strains are listed in Table 1) were spiked into plasma samples. Serial dilutions of
each spiked sample were tested with real-time RT-PCR and RT-RPA assays simultaneously (S2
Table). Limits of detection in RT-RPA were 237, 618, 363, and 383 RNAmolecules detected/re-
action of DENV serotypes 1, 2, 3, and 4, respectively (Fig 5).
Specificity and cross-reactivity of DENV1-3, and DENV4 RT-RPA
assays
Sixty-four DENV-PCR negative samples were tested by both DENV RT-RPA assays. Non-spe-
cific amplification was not detected. DENV1-3 RT-RPA assay detected DENV serotypes 1, 2,
and 3, while DENV4 RT-RPA identified DENV serotypes 2 and 4 (Table 1). No cross detection
with viruses listed in Table 2 was observed.
Mobile Detection of Dengue Virus
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Fig 3. Analytical sensitivity of DENV RT-RPA assays. A, DENV1-3 and B, DENV4 RT-RPA assays. Fluorescence development via real-time detection in
one RT-RPA run by using a dilution range of 107–101 RNAmolecules/μl of the DENV1-3 and DENV4 RNAmolecular standards (Graph generated by
ESEquant tubescanner studio software). The sensitivity was 100 and 10 RNA copies for DENV1-3 and DENV4 RT-RPA, respectively. Data of 8 RT-RPA
runs is compiled in Fig 4. The signal for ten RNA copies is very weak. The box in the lower right corner of Fig 3B magnifies the fluorescence signals for the ten
RNA copies and the negative control. 107 represented by black line; 106, gray; 105, red; 104, blue; 103, green; 102, cyan; 101, dark khaki; negative
control, orange.
doi:10.1371/journal.pone.0129682.g003
Mobile Detection of Dengue Virus
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Fig 4. Reproducibility of DENV RT-RPA assays. A, DENV1-3 and B, DENV4 RT-RPA assays. Semi-
logarithmic regression of the data collected from eight DENV RT-RPA test runs on the RNA standard using
PRISM. Both assays yielded results between 3–7 minutes. In DENV1-3 RT-RPA assay, 107–103 RNA
molecules were detected 8 out of 8 runs, 102 in 1 out of 8 and 10 copies was not identified. In DENV4
RT-RPA assay, 107–102 RNAmolecules were detected 8 out of 8 runs and 10 copies in 6/ out of 8. In Fig 4B,
the value for 10 RNA copies was consistently 5.3 minutes in all 6 cases.
doi:10.1371/journal.pone.0129682.g004
Mobile Detection of Dengue Virus
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RPAmobile laboratory in Kedougou region in Senegal
In the field, setting up the mobile laboratory including hooking electricity from a motor vehicle
battery took about 20 minutes. A magnetic beads based extraction method was used to avoid
the use of a centrifuge and the generation of aerosols.
Using the inactivated DENV1-4 spiked plasma as well as 31 DENV positive samples, the
DENV RT-RPA assays and the mobile laboratory format were tested in a healthcare center
without electricity in Bandafassi (S5 Fig) to simulate an outbreak situation. Extraction and
RT-RPA assays were carried out at an ambient temperature of 38°C. The RT-RPA assays were
used successfully to detect DENV RNA in the spiked plasma. In comparison to the real-time
RT-PCR results, 30 out of 31 DENV-3-positive samples were positive in RT-RPA assays (clini-
cal sensitivity 98%, Fig 6). Samples with high cycle threshold (Ct) value (35–38) in real-time
RT-PCR were detected by RT-RPA in a maximum of 8 minutes.
Assay performance on RNA extracts in Thailand
In Bangkok, Thailand, the RNA of ninety plasma samples extracted and tested between 2012–
2013 by RT-PCR, and stored at -80°C was tested. RNA was simultaneously screened by
RT-RPA assays and serotype specific real-time RT-PCR (S1 Table). The sensitivity was 72%
and 94.4% for RT-RPA and real-time RT-PCR, respectively (S3 Table). RT-RPA assays sensi-
tivities for DENV serotypes were 66.6% (16/24), 44% (4/9), 80.9% (34/42), and 60% (6/10) for
DENV1, 2, 3, and 4, respectively. Five samples were only positive in RT-RPA and therefore the
DENV serotype was not determined. No correlation was found between threshold time values
of RT-RPA and Ct of the real-time RT-PCR (S6 Fig, R2 = 0.179).
Fig 5. Performance of DENV RT-RPA assays on spiked plasma samples. A, sample spiked with DENV1; B, DENV2; C, DENV3; D, DENV4. DENV
serotypes 1–4 were spiked into plasma samples. Serial dilutions of each of the spiked sample were tested simultaneously with real-time RT-PCR and
RT-RPA assays (S2 Table). Limits of detection in RT-RPA assays were 237, 618, 363, and 383 RNA copies of DENV serotypes 1, 2, 3, and 4, respectively.
doi:10.1371/journal.pone.0129682.g005
Mobile Detection of Dengue Virus
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Discussion
In their review, Peeling et al., [8] mention characteristics of the future diagnostic test for early
detection of DENV. It should be rapid, sensitive, specific, stable at high temperatures (>30°C),
and cheap. Currently point-of-care DENV detection is carried out with RDT assays. RDTs are
simple and rapid but of limited sensitivity and specificity [7, 13]. Real-time RT-PCR is highly
sensitive, usually performed in highly equipped laboratories and not suitable for point-of-care
testing. In contrast, RPA technology is as sensitive and specific as real-time RT-PCR, isother-
mal and easy to use at point-of-need [26, 29–35]. In addition, RPA is fast (3–5 minutes includ-
ing the reverse transcription step) and can be performed on a portable device (tubescanner). In
this study, two RT-RPA assays for detection of DENV (DENV1-3 and DENV4) were devel-
oped which cover but do not differentially determine DENV1-4, as required for molecular epi-
demiological studies. Distinguishing DENV1-4 at the point-of-care is not clinically relevant.
The assays were very sensitive with a respective limit of detection of 241 and 14 molecules de-
tected, highly specific, and were evaluated as mobile tests in a low resource setting in Kedougou
in Senegal.
Fig 6. Comparison between real-time RT-PCR (X-axis) and RT-RPA (Y-axis) for the detection of DENV in 31 clinical samples in Senegal. Linear
regression analysis of real-time RT-PCR cycle threshold values (Ct, X-axis) and RT-RPA threshold time in minutes (TT, Y-axis) were determined by PRISM
(R2 = 0.39). The RT-RPA is much faster than the real-time RT-PCR even with samples with high Ct value.
doi:10.1371/journal.pone.0129682.g006
Mobile Detection of Dengue Virus
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Several isothermal amplification technologies were developed in the last two decades, e.g.
RT-LAMP [24], NASBA [36], nicking enzyme amplification reaction [37], rolling circle ampli-
fication methods [38], helicase dependent amplification [39], and RPA [25]. They differ in the
amplification temperature, run time, number of primers used for DNA amplification, detection
method (probe-based or intercalating dye dependent) and commercial availability.
Many RT-LAMP assays have been developed for DENV detection using between 6–24
primers [20–23] and yielding results in 30 minutes based on visual inspection (turbidity index,
fluorescence) [20–23]. While SYBR Green detection of the RT-LAMP reaction could basically
also be done with the tubescanner, RPA is much faster (3–15 minutes) and utilizes only three
oligonucleotides (two primers, one exo-P). Recent advances in software development to assist
LAMP design may help overcome challenges for highly variant viruses, the tolerance for mis-
matches in LAMP assays however still needs to be explored [40]. The tolerance of RPA oligo-
nucleotide sets and in particular, of the exo-P probe portions to mismatches [26, 33] are
advantageous for RPA amplicon design but remain subject to testing.
Previous work had shown that for RNA viruses the best sensitivity is achieved with an exo-
P, encompassing 15 nt 5’ (short section), and 30 nt 3’ (long section) of a basic site mimic (Tet-
rahydrofuran, THF) and a phosphate at the 3’ end of the exo-P [25, 26]. The phosphate blocks
any primer type interference of the long section with the RPA reaction after Exonuclease
nicking [25]. In contrast of all tested probes, DENV-RPA-P3 consisting of the standard in-
verse exo-P structure with a long 32 nt section 5’ and a short 16 nt section 3’ of the THF site
(Table 2) yielded the highest sensitivity. Here the long section can act as a primer and contrib-
ute to, the sensitivity of the assay [25] as observed for other RPA assays [29, 30].
Of all reverse primers tested DENV1-3 RP4 and DENV4 RP2 yielded the highest assay sen-
sitivities although overlapping the long exo-P 3’ section of DENV-RPA-P3 by 28 nt (S1 and S2
Figs). The best forward primer for the DENV4 assay DENV4 FP3 overlapped the short exo-P
3’ end by 6 nt (S2 Fig). Non-specific amplification was not observed in any of these cases.
Therefore, the selection of primer and probe format is still down to trial and error. The factors
that determine efficient strand invasion may be a combination of binding enthalpy and local
secondary structure. Although advances in calculating these values for PCR primers have been
made, they cannot as yet be deduced for RPA [41].
DEN RPA P3 is shared by both assays but carries 4 mismatches (S2 and S7 Figs) in the
smaller 13 nt 3’ section of the probe. Efficient RPA tolerates mismatches per primer which
should not accumulate at the termini or at the center of the primers and in concordance with
what is known about PCR primers mismatches at the 3’ end of the primers impede the RPA re-
action [42]. As a whole RPA amplification systems appear to tolerate the presence of 5–9 mis-
matches in a primer and probe set [26, 33]. We assume that the long 32 nt 5’ section of DEN
RPA P3, which matches almost perfectly to DENV1-4, allows for tolerance of the accumulation
of the mismatches in the smaller 3’ portion of the probe since it does not conflict with the prin-
ciple of dissociation of the smaller section the exo-P after Exonuclease action. Shifting the mis-
matches into the smaller section of the probes may thus be exploited for the design of exo-P for
the detection of other highly variable RNA target sequences. In contrast, real-time PCR, which
utilized shorter primers and probes, is more sensitive to the presence of mismatches in the tar-
get sequence [43]. The linearity of the assay also does not represent a correlation of linearity
and sensitivity as seen in real-time PCR assays [29].
Real-time RT-PCR can be used for both qualitative and quantitative analysis of RNA in a
sample. In contrast, RT-RPA can currently only be used for qualitative detection of RNA. As
shown in Fig 6, the TT values of the RT-RPA can be classified into two groups, before 3 and
after 5 minutes. The main reason is the interruption of the fluorescence read by the mixing
step after three minutes, which is crucial for the assay sensitivity. During mixing, fluoresces
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signal are not measured (Figs 3 and 6), therefore, TT values can`t be calculated. This however
does not lead to false negatives.
The characteristics of the mobile laboratory (23kg including the aluminium case) are 1) easy
transportation by car and airplane, 2) power source frommotor vehicle batteries or solar panel
with power pack, 3) easy implementation in low resource settings. A magnetic bead extraction was
applied to avoid the creation of aerosols and because trials at the Institute Pasteur in Paris in a cli-
mate chamber have shown that most commercial centrifuges short-circuited at 80% humidity and
temperatures above 38°C (Jean-Claude Manuguerra, personal communication). All reagents were
cold chain independent and performed well at 38–40°C ambient temperature. We were able to run
the laboratory in the open air and observed no influence of dust on the assay quality. We will con-
tinue to follow this concept to allow easy deployment of up to date molecular detection to infra-
structure poor settings. Further work will attempt to reduce pipetting steps by drying RPA primers
and probe into the RPA reagent pellet, implementing a multiplex RT-RPA assay combining the
two DENV RPA assays into one reaction and identifying even simpler extraction protocols.
The DENV RT-RPA assays were evaluated with plasma samples and RNA extracts in Sene-
gal and Thailand. The RT-RPA clinical sensitivities were 98% for samples tested in Senegal and
72% for RNA extracts in Thailand, whereas real-time RT-PCR sensitivity was 98% and 94.4%,
respectively. The lower clinical sensitivity of the RT-RPA assays on the RNA extracts in Thai-
land might not be due to the assay detection limit, which is between 10–100 RNA copies (Figs
3, 4 and 5). As shown in S3 Table, most of the samples, which were negative in RT-RPA had Ct
values between 14–30 in real-time RT-PCR. Genetic variations between Asian and African
DENV strain could not be the reason for the difference in the assay sensitivity [44–47]. As
mentioned above, the RPA targeted the conserved 3’ NTR of the DENV genome and RPA am-
plification can tolerate 5–9 mismatches. In Senegal, RNA was extracted from plasma samples
and screened directly with the RT-RPA assays, while in Thailand, RNA stored at -80°C for
6–18 months was tested. The integrity of the RNA is affected by freezing and thawing, albeit,
freezing of clinical samples has a less pronounced effect [48, 49]. It appears that in contrast to
real-time RT-PCR [50], RT-RPA performance is influenced by the quality of the RNA confirm-
ing an observation we described earlier [26].
In conclusion, two DENV RT-RPA assays were developed for rapid identification of
DENV1-4. RPA was easy to implement in low resource settings and high ambient temperatures
did not affect its performance.
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con. Three RPA exo probes (P), 19 forward primers (FP), and 5 reverse primers (RP) were test-
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molecular standard. 107 represented by black line; 106, gray; 105, red; 104, blue; 103, green; 102,
cyan; 101, dark khaki; negative control, orange.
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hospital. D, laboratory at the local hospital. E, Power supply from motor vehicle battery and
convertor. F, RPA mobile laboratory operated by power from motor vehicle battery.
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S6 Fig. Comparison between RT-RPA (Y-axis) and real-time RT-PCR (X-axis) for the de-
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cycle threshold values (Ct, X-axis) were determined using PRISM. R squared value was 0.179.
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